10 news items
CASSAVA ALERT: Bragar Eagel & Squire, P.C. is Investigating Cassava Sciences, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
SAVA
5 Apr 24
, once revealed, was likely to subject the Company to significant financial and/or reputational harm; and (v) as a result, the Company's public
Cassava Sciences, Inc. investors: Please contact the Portnoy Law Firm to recover your losses; April 2, 2024 deadline.
SAVA
1 Apr 24
these issues, upon being disclosed, were poised to inflict considerable financial and/or reputational damage on the company; andtherefore
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Cassava Sciences, Inc. of Class Action Lawsuit and Upcoming Deadlines – SAVA
SAVA
31 Mar 24
prospects of simufilam; (iv) all of the foregoing, once revealed, was likely to subject the Company to significant financial and/or reputational harm
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important April 2 Deadline in Securities Class Action – SAVA
SAVA
31 Mar 24
financial and/or reputational harm; and (5) as a result, Cassava's public statements were materially false and misleading at all relevant times. When
SAVA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cassava Sciences, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
SAVA
31 Mar 24
to significant financial and/or reputational harm; and (5) as a result, the Company's public statements were materially false and misleading
s6cccmlgy8oszuokqqxih4s6qyep1hb t0vuowo
SAVA
29 Mar 24
of the foregoing, once revealed, was likely to subject the Company to significant financial and/or reputational harm; and (v) as a result, the Company's
znt97ej4oucmnccygflfn3kdo7ipm8g31cqk90
SAVA
28 Mar 24
, once revealed, was likely to subject the Company to significant financial and/or reputational harm; and (v) as a result, the Company's public
3g4wqkc4m 3p9ct6pgsmck8wpjc3
SAVA
27 Mar 24
and/or reputational harm; and (5) as a result, Cassava's public statements were materially false and misleading at all relevant times. When the true details
w2vqimkptjbmviqp2
SAVA
27 Mar 24
the Company to significant financial and/or reputational harm; and (v) as a result, the Company's public statements were materially false
g8tc m7361
AMLX
INMD
NYCB
25 Mar 24
of simufilam; (iv) all of the foregoing, once revealed, was likely to subject the Company to significant financial and/or reputational harm; and (v
- Prev
- 1
- Next